AI-powered blood test promises early detection of ovarian cancer

A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United States and Europe.

Straumann Group appoints Yang Xu as Chief Financial Officer – Biotech Investments

Straumann Holding AG / Key word(s): Miscellaneous/Personnel Straumann Group appoints Yang Xu as Chief Financial Officer 17.07.2023 / 07:00 CET/CEST Basel, July 17, 2023: Straumann

July 18, 2023

Personalized dietary programs outperform general advice for better heart health

Study found that personalized dietary programs (PDP) led to significant improvements in cardiometabolic health compared to standard dietary advice, with notable reductions in weight, triglyceride

May 14, 2024

Merck’s women’s health spinoff Organon looks for pharmaceuticals, diagnostics, devices to fill out its pipeline

Sandra Milligan, Organon’s head of R&D, sometimes wishes the women’s health spinoff was an oncology company. In cancer, the regulatory path is well-trodden. There are

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.